TBIO
Telesis Bio, Inc. · NASDAQ
- Sector Commercial Services
- Industry Miscellaneous Commercial Services
- Website elesisbio.com
- Employees(FY) 223
- ISIN US1920032000
Performance
-25.47%
1W
-31.97%
1M
-20.86%
3M
-40.48%
6M
-37.34%
YTD
-87.68%
1Y
Profile
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system, including BioXp 3250 system, BioXp 9600 system, and BioXp DBC, which are empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits, such as BioXp De Novo kits, BioXp select kits, BioXp next generation sequencing kits, and BioXp DBC kits, which contains building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and short oligo ligation assembly enzymatic DNA synthesis designs to significantly reduce timelines for constructing synthetic DNA, RNA, and proteins compared to traditional chemical synthesis, paving the way for more efficient and effective development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Technical Analysis of TBIO 2024-05-10
Overview:
In the last 5 trading days, TBIO stock has shown mixed price movements with fluctuations in volume and technical indicators. We will analyze the trend, momentum, volatility, and volume indicators to provide insights into the possible future stock price movement.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been fluctuating, ...
Recent News & Updates
- 2024-05-09 11:55
- 2024-05-09 05:32
Telesis Bio: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-09 04:05
Telesis Bio Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-05-06 04:05
Telesis Bio Announces Reverse Stock Split(Globenewswire)
- 2024-04-17 21:00
- 2024-03-28 11:53
- 2024-03-28 04:25
Telesis Bio: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-28 04:05
- 2024-02-25 20:15
- 2024-02-22 19:44
Why Is Telesis Bio (TBIO) Stock Up 29% Today?(Investorplace)
- 2023-11-13 04:32
Telesis Bio: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-13 03:22
Telesis Bio Reports Third Quarter 2023 Financial Results(Globenewswire)
- 2023-11-06 20:00
- 2023-11-03 00:00
- 2023-09-28 03:48
- 2023-08-29 04:05
- 2023-08-10 04:51
Telesis Bio: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-10 04:05
Telesis Bio Reports Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-08-03 05:00
- 2023-06-07 21:05
- 2023-06-05 15:00
- 2023-06-05 05:30
- 2023-05-31 05:29
Telesis Bio Secures Financing of $28.0 Million(Yahoo Finance)
- 2023-05-22 21:00
Telesis Bio to Present at SynBioBeta 2023(Yahoo Finance)
- 2023-05-22 00:00
- 2023-05-17 22:00
- 2023-05-14 21:00
- 2023-05-12 20:05
- 2023-05-12 04:17
Blue Bird, First Solar rise; Harrow Health, Telesis Bio fall(Yahoo Finance)
- 2023-05-11 05:25
Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates(Yahoo Finance)
Page 1 of 2
previousnext